ArticleInternational journal of technology assessment in health care2023

Cost-effectiveness of adding ezetimibe and/or PCSK9 inhibitors to high-dose statins for secondary prevention of cardiovascular disease in Chinese adults.

Yuliang Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.